We have written about the NAION Ozempic side-effect warning issue several times over the past year-and-a-half, and have repeatedly pointed out that non-arteritic anterior ischemic optic neuropathy, or NAION, is linked to semaglutide. Moreover, we noted that semaglutide is the active ingredient in the currently available Novo Nordisk semaglutide medicines: Ozempic injection, Wegovy injection, Wegovy tablet, and Rybelsus tablet. Furthermore, we have asserted that all Novo Nordisk semaglutide medicines should carry an NAION side-effect warning.
As of late January 2026, however, there is still no NAION side-effect warning for Ozempic and Rybelsus. See “Revised: 1/2026” Prescribing Information document for “RYBELSUS and OZEMPIC tablets” [PDF document]. And there is no NAION side-effect warning for Wegovy.
Here are two earlier articles from our Drug Injury Watch blog that provide support for our assertion that there should be an NAION Ozempic side-effect warning in that January 2026 drug label for the new pill version of Ozempic, soon to be available, as well as the current drug label for the already available, and popular, Ozempic injection:
- “Risk of NAION With Semaglutide Medicines is 2 Times Higher Than SGLT2i Diabetes Drugs” (2/13/2026)
- “Wegovy and Ozempic Increase NAION Risk, an Eye Side Effect That Can Result in Blindness” (10/22/2025)
NAION Ozempic Side-Effect Warning Lawsuits
The failure by Novo Nordisk to have an NAION side-effect warning available for doctors who prescribe Ozempic, as well as the people who use Ozempic, is the basis for drug injury lawsuits that have been filed against this pharmaceutical company on behalf of people diagnosed with NAION. These Ozempic lawsuits are product liability cases based in part on a failure-to-warn allegation.
A person diagnosed with NAION while using Ozempic, Wegovy, or Rybelsus — the Novo Nordisk semaglutide medicines — may want to submit an Ozempic / Wegovy / Rybelsus Vision Loss Case Evaluation Form online. It is free, confidential, and there is no obligation.
In the alternative, if you have a possible Wegovy, Rybelsus, or Ozempic NAION lawsuit that you want evaluated by attorney Tom Lamb, you can send an email to TJL@LambLawOffice.com or call 910-256-2971.
Ozempic / Wegovy / Rybelsus
Free Case Evaluation
Strictly Confidential, No Obligation